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In this issue of Cell Host & Microbe, Chamanian et al. (2013) show that the frameshifting region in the HIV-1
genome influences the efficiency of genome packaging. This study may provide insights into mechanisms
that constrain retroviruses into packaging only two copies of the genome during retroviral assembly.The mechanism by which retroviruses
selectively package their RNA genomes
has been a topic of intensive research
for more than three decades. Retrovi-
ruses are unique in that their genomes
are made up of two copies of the full-
length, unspliced mRNA. This genomic
mRNA—transcribed by the host cellular
machinery with reverse-transcribed viral
DNA as a template—is also used for
translating the essential Gag and Gag-
Pol viral proteins (D’Souza and Summers,
2005). The virion is thus required to effi-
ciently discriminate its genome from
a pool of excess cellular mRNA prior to
budding.
A region called the packaging signal
(J site) present in the 50 untranslated
region (50UTR) of the mRNA is known to
dictate this specificity (Figure 1). Specific
sequences in the J site are capable of
binding to the nucleocapsid (NC) domain
of the viral Gag protein, thus allowing the
genome to be integrated into assembling
virions. Furthermore, the J site also typi-
cally contains dimerization determinants,
enabling thevirion toencapsidateadiploid
genome (D’Souza and Summers, 2005).
Recent work in HIV-1 suggests that the
dual function (translational versus
genomic) and the dual state (monomeric
versus dimeric) of the viral RNA may be
correlated. Briefly, the J site of the
mRNA can be maintained in two confor-
mations: the monomeric form has the
NC-binding sequences and dimerization
initiation site (DIS) sequestered and the
Gag start codon exposed, which makes
the mRNA translation competent, while
a switch to the dimeric conformation
sequesters the stop codon and exposes
the NC-binding site and makes the
mRNA competent for packaging (Lu
et al., 2011). In HIV-1 it is thus currently
believed that there exists a single pool of
mRNA that can be driven by the J siteto switch between equilibrating confor-
mations, which in turn determines the
immediate fate of the mRNA (Lu et al.,
2011; Butsch and Boris-Lawrie, 2002).
While the critical role of the J site as
the major determinant for genome dimer-
ization and encapsidation has been
conclusively established, additional con-
tributions from sequences in the 50UTR
near the J site, including the TAR,
Poly(A), and U5-PBS domains, as well
as sequences further downstream into
the Gag coding region, have been re-
ported (Heng et al., 2012). All of these
contributions, however, have been ques-
tioned by additional research. One of
the reasons for inconsistencies arises
from the fact that these domains play an
important role in other functions that are
critical for retroviral replication. In addi-
tion, mutations of these distinct domains
are capable of perturbing theJ site struc-
ture. Thus, in these cases, the observed
defects in genome packaging could be
an indirect or secondary effect. In fact,
recent studies that ensure maintenance
of the correct three-dimensional structure
of the J site have concluded that these
additional domains do not significantly
contribute to packaging specificity and
levels (Heng et al., 2012).
There are, however, key questions that
remain unanswered in the field. For
example, why are only two genomes
packaged per virion? Are there other
determinants present in the viral mRNA
itself, or viral proteins and/or host factors
that allow for only a fraction of the
mRNA to become competent for pack-
aging and thus limit the number the
genomes packaged per virion?
A new study by Chamanian and
colleagues in this issue of Cell Host &
Microbe (Chamanian et al., 2013) sug-
gests that a sequence even further
downstream into the HIV-1 mRNA-codingCell Host & Microbe 13,region, specifically at the Gag-Pol junc-
tion, contributes to packaging (Figure 1).
But unlike the other domains that were
speculated to only contribute to the pack-
aging efficiency, this study suggests that
the region may hold clues to the above
open questions. The authors start by
defining the domain as a ‘‘genomic RNA
packaging enhancer’’ (GRPE) after find-
ing that deletion of this sequence from
awild-type construct, containing an intact
50UTR, causes a 7-fold decrease in pack-
aging efficiency. The authors then per-
form in vitro SHAPE analysis (a chemical
probing method that maps secondary
structure) of the GRPE in RNA constructs
designed to change the spacing between
50UTR and the GRPE. They find that
constructs that cause perturbation of the
GRPE structure also cause a decrease in
genome packaging.
Interestingly, the GRPE contains a fra-
meshifting signal that dictates the 5%
ribosomal recoding frequency in HIV-1.
Recoding, either by frameshifting (in
HIV-1) or stop codon readthrough (as in
murine leukemia virus, MLV) is required
for the production of the critical 20:1
Gag to Gag-Pol protein ratio in retrovi-
ruses. To probe for a possible connec-
tion between frameshifting frequencies
and genome packaging, the authors
sought to manipulate frameshifting levels
by knocking down eRF1, a host factor
that has been reported to modulate fra-
meshifting (Kobayashi et al., 2010). In
this scenario, the authors observe a
10-fold increase in genomes being
packaged per Gag molecule, i.e., 20
genomes are packaged per virion. The
authors then use previously observed
correlations to the nonsense-mediated
mRNA decay (NMD) pathway to describe
a model for their findings. First, eRF1
is directly implicated in NMD, and
hence bypassing the stop codon duringFebruary 13, 2013 ª2013 Elsevier Inc. 123
stop
Translation terminates 
Gag
~95% 3’
5’
AUG
Upf1
eRF1
Nonsense-mediated decay
Translation continues 
in -1 frame
Gag Gag-Pol
~5%
3’
5’
5’
5’
Gag
AUG
?
Genome packaging
TAR
U5-PBS
Poly(A)
GRPE
Ψ-site
A
B
5’-UTR
DIS
Figure 1. Potential Relationship between Ribosomal Frameshifting and Genome Packaging
in HIV-1
(A) Approximately ninety-five percent of the viral mRNA terminates at the stop codon after translating the
Gag protein. The 50UTR consisting of theJ site, TAR, Poly(A), and U5-PBS is in the translation-competent
conformation with the DIS (orange) sequestered. Recruitment of eRF1 and Upf1 designates this fraction of
the mRNA for NMD.
(B) Only 5% of the viral mRNA undergoes frameshifting and continues translation in the 1 frame, thus
bypassing the stop codon and translating the Gag-Pol fusion protein. This fraction of the mRNA may
be protected from NMD, allowing for a potential long-range interaction between the GRPE and the dimer-
ized J site, which in turn facilitates dimeric genome packaging.
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fraction of mRNA from NMD. Second,
the recoding signal itself (at least in
MLV) has been shown to inhibit decay
by blocking RNA binding of Upf1, which
is a nonspecific RNA helicase compo-
nent of the NMD surveillance complex
(Hogg and Goff, 2010). The authors
suggest that after Gag translation the
interactions of eRF1, Upf1, and associ-
ated NMD factors may preclude forma-
tion of long-range interactions between
the GRPE and the J site. When frame-
shifting does occur, eRF1 and the
NMD factors are dissociated from the
RNA by translating ribosomes poten-
tially allowing the formation of long-range
interactions necessary for packaging.
Thus, the authors speculate that only
5% of mRNA that allow for frameshifting
may be resistant to NMD and therefore
destined for packaging (Figure 1).
From the current study it is not clear
if the regulatory effect of the GRPE
on packaging arises due to direct
contacts between the frameshifting
signal and the 50UTR. It has recently
been shown that the frequency of recod-124 Cell Host & Microbe 13, February 13, 201ing in MLV is regulated by a dynamic, pre-
existing, structural equilibrium between
two conformations of the recoding signal:
an active conformer that is permissive
for recoding, and an alternate, inactive
conformer that terminates translation
(Houck-Loomis et al., 2011). It is possible
that HIV-1 frameshifting frequency is also
maintained by multiple conformations,
each having a distinct fate, but this
possibility has yet to be investigated.
Since change in local structure can have
long-range effects, it is possible that the
same riboswitch that induces a frame-
shifting permissible conformation also
leads to the packaging competent
structure in the 50UTR, thus linking the
two processes without necessitating a
direct interaction between the frame-
shifting signal and the 50UTR. In fact,
long-range influences from TAR-Poly(A)
in the 50UTR have been shown to influ-
ence the efficiency of the distally located
frameshifting signal by interfering with
translation initiation (Charbonneau et al.,
2012).
Linking eRF1 levels to packaging
is intriguing because this observation3 ª2013 Elsevier Inc.potentially links regulation of ribosomal
translation to genome packaging. How-
ever, pulse-chase experiments have
shown that inhibition of translation in
HIV-1-infected T cells does not affect
RNA packaging, and hence de novo
translation is not thought to be a re-
quirement for packaging in HIV-1
(Butsch and Boris-Lawrie, 2002). The
new model is thus a bold departure
and, as the authors note, warrants
further investigation to determine the
exact cause for deregulation of diploid
genome packaging upon eRF1 downre-
gulation. An important experiment will
be to correlate packaging levels directly
with frameshifting levels. The sequence
requirements for the HIV-1 frameshifting
signal have been extensively studied by
mutagenesis (Mouzakis et al., 2012). It
should, in theory, be possible to investi-
gate whether modulation of frameshifting
directly leads to the predicted effects on
packaging. However, mutations known
to abrogate recoding in MLV are still
able to protect the mRNA from NMD
(Hogg and Goff, 2010), suggesting that
recoding signal does not need to have
an active conformation to exert its
effect. Thus, in order to directly correlate
frameshifting levels with genome pack-
aging, hyperactive frameshifting mutants
may be required (Mouzakis et al., 2012).
This should, in principle, lead to a
greater fraction of mRNA that escapes
NMD and hence allow for packaging of
more genomes. Furthermore, advances
in NMR spectroscopy using specific
labeling techniques and emerging high-
resolution structural data may now allow
direct probing of putative interactions
between the GPRE and the J site (Lu
et al., 2011).
The findings of this study are excit-
ing and may finally set the stage for
understanding critical regulatory events
that lead to diploid retroviral genome
packaging.REFERENCES
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Malaria during pregnancy is a major factor in infant morbidity and mortality. In this issue of Cell Host and
Microbe, Conroy et al. (2013) propose that C5a, a product of complement cascade activation, counteracts
the placental vascular remodeling response induced byPlasmodium infection and contributes to fetal growth
restriction.In Maori tradition, the placenta (whenua in
the language ofMaori) is buried upon birth
to establish a link between the land (like-
wise called whenua) and the newborn.
Both types of whenua nourish: ‘‘One
allows the foetus to become a baby with
all the potential to become a strong and
healthy adult, and the other sees that
person develop and grow, make their
contribution to society and then be ‘born’
into the spirit of the world’’ (Head and
Head, 2003). Although the placenta is
credited with the developing fetus,
surprisingly little is known about critical
molecules and physiological parameters
that control the functional efficacy of this
fast-growing organ and determine preg-
nancy success.
Fetal growth restriction is a severe
consequence of malarial disease
during pregnancy and thought to result
largely from placental insufficiency.
Much research has been centered on
the pathogenic role of ligand-receptor
interactions between the Plasmodium-
infected erythrocyte and placental
tissues (reviewed by Duffy and Fried,
2005). Parasite antigens expressed on
the surface of infected erythrocytes
are thought to contribute to accu-
mulation of parasitized cells in the
placenta. The best example is var2csa,member of the var (variable surface
antigen) gene family that is selectively
expressed by infected erythrocytes that
accumulate in the placenta (Salanti
et al., 2003). VAR2CSA has strong affinity
to the glycosaminoglycan chondrotin
sulfate A (CSA or C4S) present in high
amounts in the intervillous space and
on the surface of syncytiotrophoblasts,
which contact the maternal blood. The
current pathogenesis model is focused
on linking placental sequestration of
infected erythrocytes to a series of
inflammatory events that can reduce
fetal growth. Cytoadhesion of infected
erythrocytes can activate syncytiotro-
phoblast cells to secrete chemokines,
which attract maternal inflammatory
cells (Lucchi et al., 2008). But how does
inflammation impair maternal-fetal
exchange? Little attention has been
paid to the impact of malaria on physi-
ology of the fast-developing placenta
that in the course of infection may con-
tribute to placental insufficiency.
Recently the pathogenesis paradigm
was challenged by work that addresses
the role of angiogenesis factors (re-
viewed by Conroy et al., 2011), the
coagulation cascade (Avery et al.,
2012), and placental microcirculation
(Moraes et al., 2013).In this issue, Conroy et al. (2013) inves-
tigate potential links between inflamma-
tion, angiogenesis alterations, and fetal
growth restriction in pregnancy-associ-
ated malaria. They focus on activation
of the complement cascade, previously
shown to impair placental vascular re-
modeling in mouse models of miscarriage
or fetal growth restriction (reviewed by
Girardi, 2008). Complement cascade
activation by immune complexes in the
placenta may indirectly contribute to
inflammation. C5a—a protein fragment
released by the activation of C5 comple-
ment component—was shown to be
implicated in tissue injury by inducing
release of reactive oxygen species of
C5a-activated neutrophils. Nevertheless,
in antibody-independent models of
unsuccessful pregnancy, inflammatory
cells indirectly generate C5a fractions
that activate monocytes to produce
soluble vascular endothelial growth factor
(sVEGF), an inhibitor of VEGF. This dereg-
ulation of angiogenic factors is hypothe-
sized to disturb the developing placental
vascularization and as a consequence
impeding babies of getting appropriate
nurturing.
The study by Conroy et al. (2013)
tackles this issue and provides epidemio-
logical data and compelling experimentalFebruary 13, 2013 ª2013 Elsevier Inc. 125
